Author

Cheng Zeng

Wuhan University of TechnologyORCID 0009-0004-3706-7900Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Kai Yang· 1 shared Lei SheniD· 1 shared Taolei SuniD· 1 shared Xinyue ZhaoiD· 1 shared Zhupeng Xiao· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Kai Yang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Au18(L-NIBC)14 targets ASC oligomerization for autoimmune disease treatment

Kai Yang, Xinyue Zhao, Zhupeng Xiao, Cheng Zeng, Lei Shen, Taolei Sun

This study identifies Au18(L-NIBC)14 as a gold nanocluster that targets ASC oligomerization, reducing inflammasome activation and improving symptoms in autoimmune disease models.

bioRxiv · Mar 25, 2025 · PreprintPharmacology & Toxicology